AUD 1.89
(-0.53%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 | -1.61 Million AUD | 85.23% |
2023 | -10.92 Million AUD | -4.4% |
2022 | -10.46 Million AUD | -2.77% |
2021 | -10.18 Million AUD | -99.17% |
2020 | -5.11 Million AUD | -72.84% |
2019 | -2.95 Million AUD | -121.25% |
2018 | -1.33 Million AUD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q4 | -2.13 Million AUD | 0.0% |
2024 FY | -13.47 Million AUD | -23.32% |
2024 Q2 | -6.33 Million AUD | 0.0% |
2023 Q2 | -5.71 Million AUD | 0.0% |
2023 FY | -10.92 Million AUD | -4.4% |
2023 Q4 | -5.21 Million AUD | 0.0% |
2022 FY | -10.46 Million AUD | -2.77% |
2022 Q2 | -5.46 Million AUD | 0.0% |
2022 Q4 | -5 Million AUD | 0.0% |
2021 Q2 | -4.87 Million AUD | 0.0% |
2021 FY | -10.18 Million AUD | -99.17% |
2021 Q4 | -5.3 Million AUD | 0.0% |
2020 FY | -5.11 Million AUD | -72.84% |
2020 Q4 | -2.18 Million AUD | 0.0% |
2020 Q2 | -2.93 Million AUD | 0.0% |
2019 Q4 | -2.06 Million AUD | -88.8% |
2019 Q3 | -1.09 Million AUD | 33.06% |
2019 Q2 | -1.63 Million AUD | 0.0% |
2019 FY | -2.95 Million AUD | -121.25% |
2018 Q2 | -312.43 Thousand AUD | -100.0% |
2018 FY | -1.33 Million AUD | 0.0% |
2018 Q1 | -156.21 Thousand AUD | 0.0% |
2018 Q4 | -532.15 Thousand AUD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
4DMedical Limited | -27.96 Million AUD | 94.227% |
Adherium Limited | -11.98 Million AUD | 86.53% |
Aroa Biosurgery Limited | -9.78 Million AUD | 83.506% |
Atomo Diagnostics Limited | -4.36 Million AUD | 62.985% |
Anteris Technologies Ltd | -66.63 Million AUD | 97.577% |
Control Bionics Limited | -5.92 Million AUD | 72.772% |
CardieX Limited | -4.63 Million AUD | 65.159% |
Compumedics Limited | -269 Thousand AUD | -500.152% |
Cochlear Limited | 521.5 Million AUD | 100.31% |
CleanSpace Holdings Limited | -4.81 Million AUD | 66.464% |
Cyclopharm Limited | -9.22 Million AUD | 82.499% |
Nova Eye Medical Limited | -3.79 Million AUD | 57.482% |
HeraMED Limited | -6.42 Million AUD | 74.885% |
Imricor Medical Systems, Inc. | -17.57 Million AUD | 90.814% |
ImpediMed Limited | -19.03 Million AUD | 91.519% |
InhaleRx Limited | -1.38 Million AUD | -16.439% |
LBT Innovations Limited | -4.74 Million AUD | 65.941% |
Micro-X Limited | -13.02 Million AUD | 87.607% |
Neurotech International Limited | -5.58 Million AUD | 71.093% |
OncoSil Medical Limited | -11.98 Million AUD | 86.529% |
PolyNovo Limited | 1.16 Million AUD | 238.814% |
Respiri Limited | -7 Million AUD | 76.938% |
SomnoMed Limited | -3.84 Million AUD | 57.972% |
Universal Biosensors, Inc. | -16.68 Million AUD | 90.321% |
Uscom Limited | -2.4 Million AUD | 32.855% |
Visioneering Technologies, Inc. | -5.85 Million AUD | 72.423% |